Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4764130
Max Phase: Preclinical
Molecular Formula: C52H65ClN10O11S
Molecular Weight: 1073.67
Molecule Type: Unknown
Associated Items:
ID: ALA4764130
Max Phase: Preclinical
Molecular Formula: C52H65ClN10O11S
Molecular Weight: 1073.67
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCOCCNCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1
Standard InChI: InChI=1S/C52H65ClN10O11S/c1-31(2)74-42-28-36(33(5)27-40(42)59-52-56-29-37(53)48(61-52)58-38-10-6-7-12-43(38)75(70,71)32(3)4)34-15-20-62(21-16-34)22-17-44(64)55-19-24-73-26-25-72-23-18-54-30-46(66)57-39-11-8-9-35-47(39)51(69)63(50(35)68)41-13-14-45(65)60-49(41)67/h6-12,27-29,31-32,34,41,54H,13-26,30H2,1-5H3,(H,55,64)(H,57,66)(H,60,65,67)(H2,56,58,59,61)
Standard InChI Key: OOLZSXPEPPATOF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1073.67 | Molecular Weight (Monoisotopic): 1072.4244 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Yan G,Zhong X,Yue L,Pu C,Shan H,Lan S,Zhou M,Hou X,Yang J,Li R. (2021) Discovery of a PROTAC targeting ALK with in vivo activity., 212 [PMID:33453602] [10.1016/j.ejmech.2020.113150] |
Source(1):